Wayzata, MN – March 5, 2007

Dr. John P. Vasilakos joins Biothera as Vice President, Immunology

Andcor Companies, Inc., the venture catalyst for Minnesota's most promising growth companies, is pleased to announce it has placed John P. Vasilakos, Ph.D., as vice president of Immunology of Biothera. Dr. Vasilakos will lead the company’s biology/immunology research, including management of the company’s research collaborations.

Dr. Vasilakos is one of the pharmaceutical industry's leading experts in innate immunology. Previously, he was an Advanced Research Specialist at 3M Pharmaceuticals and has held research positions at Parke-Davis Pharmaceutical Research Company (Pfizer) and Eli Lilly and Company. During the past decade, his work has focused on the discovery and development of compounds for immune response modification/potentiation for oncology, chronic viral diseases and vaccine adjuvants.

In addition to internal research, Dr. Vasilakos will manage Biothera's research collaborations, which include The Mayo Clinic, Brown University, the University of Louisville, the National Institute of Allergy and Infectious Diseases and the U.S. Department of Defense. Dr. Vasilakos has a Ph.D. in Immunology from the University of Cincinnati Medical School and a MS in Immunology from Wright State University Medical School.

About Biothera, the Immune Health Company

Biothera is a biotechnology company dedicated to improving immune health. The company's primary focus is developing pharmaceuticals that engage the immune system to fight cancer and that produce white blood cells following chemotherapy or radiation. In addition, Biothera manufactures and markets food-grade ingredients that support healthy immune function to the nutritional supplement, functional food, cosmetic and animal nutrition markets.